Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05053152
What this trial is testing

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

Who this might be right for
Oligometastatic Prostate CarcinomaProstate AdenocarcinomaProstate Ductal Adenocarcinoma+2 more
NRG Oncology 194
Not applicableStudy completedNCT02454647
What this trial is testing

Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients

Who this might be right for
Gastric CancerAdenocarcinomaEffects of Chemotherapy+2 more
Clinica Universidad de Navarra, Universidad de Navarra 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT04266249
What this trial is testing

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+6 more
ECOG-ACRIN Cancer Research Group 2,175
Not applicableStudy completedNCT00148655
What this trial is testing

Educational Interventions for Patients With DCIS

Who this might be right for
DCIS
Dana-Farber Cancer Institute 120
Early research (Phase 1)Not Yet RecruitingNCT07716735
What this trial is testing

Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer

Who this might be right for
Advanced Kidney CarcinomaAdvanced Renal Cell CarcinomaHereditary Leiomyomatosis and Renal Cell Carcinoma+6 more
Jonsson Comprehensive Cancer Center 18
Early research (Phase 1)Study completedNCT00335998
What this trial is testing

Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies

Who this might be right for
Recurrent Cervical CancerRecurrent Ovarian Epithelial CancerRecurrent Vaginal Cancer+15 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Temporarily pausedNCT06211933
What this trial is testing

Evaluation of the High Intensity Focused Ultrasound (HIFU) Technique for Patients With Unresectable Pancreatic Tumor Treatment (PULS)

Who this might be right for
Non-Resectable Pancreas Carcinoma
Centre Leon Berard 26
Not applicableStudy completedNCT03305133
What this trial is testing

Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC)

Who this might be right for
Large Cell Lung CancerNeuroendocrine Carcinoma of Lung (Diagnosis)
Groupe Francais De Pneumo-Cancerologie 86
Early research (Phase 1)Ended earlyNCT02919449
What this trial is testing

Dose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With Atezolizumab

Who this might be right for
Recurrent Non-Small Cell Lung Cancer
Vyriad, Inc. 2
Early research (Phase 1)Looking for participantsNCT07182149
What this trial is testing

NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Who this might be right for
HNSCCESCCEsophageal Adenocarcinoma+7 more
Normunity AccelCo, Inc. 150
Early research (Phase 1)UnknownNCT02577458
What this trial is testing

Study of the Combination of CM082 With Everolimus in Patients With mRCC

Who this might be right for
Renal Cell Carcinoma Recurrent
AnewPharma 18
Testing effectiveness (Phase 2)Study completedNCT00055978
What this trial is testing

Celecoxib in Preventing Lung Cancer in Former Heavy Smokers

Who this might be right for
Lung Cancer
University of California, Los Angeles 112
Testing effectiveness (Phase 2)Looking for participantsNCT07699185
What this trial is testing

Neoadjuvant Cardonilizumab Combined With Neoadjuvant Chemoradiotherapy Can Resect Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Tongji Hospital 336
Not applicableStudy completedNCT07827885
What this trial is testing

20-Fr Versus 24-Fr Chest Drains After Uniportal VATS Lobectomy for NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Fondazione Policlinico Universitario Campus Bio-Medico 80
Testing effectiveness (Phase 2)Looking for participantsNCT06780085
What this trial is testing

Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 96
Not applicableActive Not RecruitingNCT04001543
What this trial is testing

Efficacy of an Oral Immunomodulatory Nutrient on Survival During Postoperative Concomitant Chemoradiotherapy in Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Institut du Cancer de Montpellier - Val d'Aurelle 27
Not applicableLooking for participantsNCT07527143
What this trial is testing

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

Who this might be right for
Endometrial Carcinoma
Mayo Clinic 25
Testing effectiveness (Phase 2)Looking for participantsNCT06567015
What this trial is testing

Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Pierre Fabre Medicament 171
Testing effectiveness (Phase 2)Ended earlyNCT05500508
What this trial is testing

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Who this might be right for
CancerSolid TumorSolid Carcinoma+17 more
Aminex Therapeutics, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00714025
What this trial is testing

A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of Chemotherapy

Who this might be right for
Transitional Cell Carcinoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 40
Next Page